| Year |
Citation |
Score |
| 2024 |
Leis AM, Wagner A, Flannery B, Chung JR, Monto AS, Martin ET. Evaluation of test-negative design estimates of influenza vaccine effectiveness in the context of multiple, co-circulating, vaccine preventable respiratory viruses. Vaccine. 42: 126493. PMID 39476473 DOI: 10.1016/j.vaccine.2024.126493 |
0.402 |
|
| 2024 |
White EB, Grant L, Mak J, Olsho L, Edwards LJ, Naleway A, Burgess JL, Ellingson KD, Tyner H, Gaglani M, Lutrick K, Caban-Martinez A, Newes-Adeyi G, Duque J, Yoon SK, ... ... Flannery B, et al. Influenza Vaccine Effectiveness Against Illness and Asymptomatic Infection in 2022-2023: A Prospective Cohort Study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 39446477 DOI: 10.1093/cid/ciae491 |
0.418 |
|
| 2024 |
King JP, Nguyen HQ, Kiniry EL, Phillips CH, Gaglani M, Martin ET, Geffel KM, Nowalk MP, Chung JR, Flannery B, Belongia EA. Elevated body mass index is not significantly associated with reduced influenza vaccine effectiveness. Scientific Reports. 14: 21466. PMID 39271784 DOI: 10.1038/s41598-024-72081-z |
0.358 |
|
| 2024 |
Tenforde MW, Weber ZA, Yang DH, DeSilva MB, Dascomb K, Irving SA, Naleway AL, Gaglani M, Fireman B, Lewis N, Zerbo O, Goddard K, Timbol J, Hansen JR, Grisel N, ... ... Flannery B, et al. Influenza Vaccine Effectiveness Against Influenza A-Associated Emergency Department, Urgent Care, and Hospitalization Encounters Among US Adults, 2022-2023. The Journal of Infectious Diseases. 230: 141-151. PMID 39052725 DOI: 10.1093/infdis/jiad542 |
0.392 |
|
| 2024 |
Sumner KM, Yadav R, Noble EK, Sandford R, Joshi D, Tartof SY, Wernli KJ, Martin ET, Gaglani M, Zimmerman RK, Talbot HK, Grijalva CG, Belongia EA, Chung JR, Rogier E, ... ... Flannery B, et al. Anti-SARS-CoV-2 Antibody Levels Associated With COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu Vaccine Effectiveness Network, October 2021-June 2022. The Journal of Infectious Diseases. 230: 45-54. PMID 39052724 DOI: 10.1093/infdis/jiae090 |
0.633 |
|
| 2024 |
Sandford R, Yadav R, Noble EK, Sumner K, Joshi D, Tartof SY, Wernli KJ, Martin ET, Gaglani M, Zimmerman RK, Talbot HK, Grijalva CG, Belongia EA, Carlson C, Coughlin M, ... Flannery B, et al. Antibody Response to Symptomatic Infection With SARS-CoV-2 Omicron Variant Viruses, December 2021-June 2022. Influenza and Other Respiratory Viruses. 18: e13339. PMID 39012045 DOI: 10.1111/irv.13339 |
0.565 |
|
| 2024 |
Boyce TG, Levine MZ, McClure DL, King JP, Flannery B, Nguyen HQ, Belongia EA. Antibody response to sequential vaccination with cell culture, recombinant, or egg-based influenza vaccines among U.S. adults. Human Vaccines & Immunotherapeutics. 20: 2370087. PMID 38982712 DOI: 10.1080/21645515.2024.2370087 |
0.394 |
|
| 2024 |
Chung JR, Shirk P, Gaglani M, Mutnal MB, Nowalk MP, Moehling Geffel K, House SL, Curley T, Wernli KJ, Kiniry EL, Martin ET, Vaughn IA, Murugan V, Lim ES, Saade E, ... ... Flannery B, et al. Late-Season Influenza Vaccine Effectiveness Against Medically Attended Outpatient Illness, United States, December 2022-April 2023. Influenza and Other Respiratory Viruses. 18: e13342. PMID 38923314 DOI: 10.1111/irv.13342 |
0.38 |
|
| 2024 |
Bi Q, Dickerman BA, Nguyen HQ, Martin ET, Gaglani M, Wernli KJ, Balasubramani GK, Flannery B, Lipsitch M, Cobey S. Reduced effectiveness of repeat influenza vaccination: distinguishing among within-season waning, recent clinical infection, and subclinical infection. The Journal of Infectious Diseases. PMID 38687898 DOI: 10.1093/infdis/jiae220 |
0.406 |
|
| 2024 |
King JP, Chung JR, Donahue JG, Martin ET, Leis AM, Monto AS, Gaglani M, Dunnigan K, Raiyani C, Saydah S, Flannery B, Belongia EA. Post-recovery health domain scores among outpatients by SARS-CoV-2 testing status during the pre-Delta period. Bmc Infectious Diseases. 24: 300. PMID 38454352 DOI: 10.1186/s12879-024-09108-3 |
0.311 |
|
| 2024 |
Frutos AM, Price AM, Harker E, Reeves EL, Ahmad HM, Murugan V, Martin ET, House S, Saade EA, Zimmerman RK, Gaglani M, Wernli KJ, Walter EB, Michaels MG, Staat MA, ... ... Flannery B, et al. Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness - United States. Mmwr. Morbidity and Mortality Weekly Report. 73: 168-174. PMID 38421935 DOI: 10.15585/mmwr.mm7308a3 |
0.637 |
|
| 2024 |
Liu F, Gross FL, Joshi S, Gaglani M, Naleway AL, Murthy K, Groom HC, Wesley MG, Edwards LJ, Grant L, Kim SS, Sambhara S, Gangappa S, Tumpey T, Thompson MG, ... ... Flannery B, et al. Redirecting antibody responses from egg-adapted epitopes following repeat vaccination with recombinant or cell culture-based versus egg-based influenza vaccines. Nature Communications. 15: 254. PMID 38177116 DOI: 10.1038/s41467-023-44551-x |
0.412 |
|
| 2023 |
Sandford R, Yadav R, Noble EK, Sumner K, Joshi D, Tartof SY, Wernli KJ, Martin ET, Gaglani M, Zimmerman RK, Talbot HK, Grijalva CG, Belongia EA, Carlson C, Coughlin M, ... Flannery B, et al. Antibody response to symptomatic infection with SARS-CoV-2 Omicron variant viruses, December 2021-June 2022. Medrxiv : the Preprint Server For Health Sciences. PMID 38014151 DOI: 10.1101/2023.11.17.23298700 |
0.572 |
|
| 2023 |
Tenforde MW, Dawood FS, Ellington SR, Grohskopf LA, Flannery B, Garg S, Reed C. Communicating the Value of Influenza Vaccines to Patients: Translating Vaccine Effectiveness to Acceptance. Annals of Internal Medicine. PMID 38011706 DOI: 10.7326/M23-2802 |
0.349 |
|
| 2023 |
Adams K, Weber ZA, Yang DH, Klein NP, DeSilva MB, Dascomb K, Irving SA, Naleway AL, Rao S, Gaglani M, Flannery B, Garg S, Kharbanda AB, Grannis SJ, Ong TC, et al. Vaccine Effectiveness Against Pediatric Influenza-A-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022-2023 Season, VISION Network. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 37972288 DOI: 10.1093/cid/ciad704 |
0.398 |
|
| 2023 |
Ahmed F, Nowalk MP, Zimmerman RK, Bear T, Grijalva CG, Talbot HK, Florea A, Tartof SY, Gaglani M, Smith M, McLean HQ, King JP, Martin ET, Monto AS, Phillips CH, ... ... Flannery B, et al. Work Attendance with Acute Respiratory Illness Before and During COVID-19 Pandemic, United States, 2018-2022. Emerging Infectious Diseases. 29. PMID 37917142 DOI: 10.3201/eid2912.231070 |
0.576 |
|
| 2023 |
Sumner KM, Yadav R, Noble EK, Sandford R, Joshi D, Tartof SY, Wernli KJ, Martin ET, Gaglani M, Zimmerman RK, Talbot HK, Grijalva CG, Chung JR, Rogier E, Coughlin MM, ... Flannery B, et al. Anti-SARS-CoV-2 Antibody Levels Associated with COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu VE Network, October 2021-June 2022. Medrxiv : the Preprint Server For Health Sciences. PMID 37790578 DOI: 10.1101/2023.09.21.23295919 |
0.585 |
|
| 2023 |
Schmader KE, Liu CK, Flannery B, Rountree W, Auerbach H, Barnett ED, Schlaudecker EP, Todd CA, Poniewierski M, Staat MA, Harrington T, Li R, Broder KR, Walter EB. Immunogenicity of adjuvanted versus high-dose inactivated influenza vaccines in older adults: a randomized clinical trial. Immunity & Ageing : I & A. 20: 30. PMID 37393237 DOI: 10.1186/s12979-023-00355-7 |
0.37 |
|
| 2023 |
Naleway AL, Kim SS, Flannery B, Levine MZ, Murthy K, Sambhara S, Gangappa S, Edwards LJ, Ball S, Grant L, Zunie T, Cao W, Gross FL, Groom H, Fry AM, et al. Immunogenicity of High-Dose Egg-Based, Recombinant, and Cell Culture-Based Influenza Vaccines Compared With Standard-Dose Egg-Based Influenza Vaccine Among Health Care Personnel Aged 18-65 Years in 2019-2020. Open Forum Infectious Diseases. 10: ofad223. PMID 37305842 DOI: 10.1093/ofid/ofad223 |
0.382 |
|
| 2023 |
Tartof SY, Xie F, Yadav R, Wernli KJ, Martin ET, Belongia EA, Gaglani M, Zimmerman RK, Talbot HK, Thornburg N, Flannery B. Prior SARS-CoV-2 infection and COVID-19 vaccine effectiveness against outpatient illness during widespread circulation of SARS-CoV-2 Omicron variant, US Flu VE network. Influenza and Other Respiratory Viruses. 17: e13143. PMID 37246146 DOI: 10.1111/irv.13143 |
0.629 |
|
| 2023 |
Williams KV, Li ZN, Zhai B, Alcorn JF, Nowalk MP, Levine MZ, Kim SS, Flannery B, Moehling Geffel K, Merranko AJ, Collins M, Susick M, Clarke KS, Zimmerman RK, Martin JM. A randomized controlled trial to compare immunogenicity to cell-based vs. live-attenuated influenza vaccines in children. Journal of the Pediatric Infectious Diseases Society. PMID 37232430 DOI: 10.1093/jpids/piad033 |
0.378 |
|
| 2023 |
Kniss K, Sumner KM, Tastad KJ, Lewis NM, Jansen L, Julian D, Reh M, Carlson E, Williams R, Koirala S, Buss B, Donahue M, Palm J, Kollmann L, Holzbauer S, ... ... Flannery B, et al. Risk for Infection in Humans after Exposure to Birds Infected with Highly Pathogenic Avian Influenza A(H5N1) Virus, United States, 2022. Emerging Infectious Diseases. 29. PMID 37095080 DOI: 10.3201/eid2906.230103 |
0.307 |
|
| 2023 |
Bi Q, Dickerman BA, McLean HQ, Martin ET, Gaglani M, Wernli KJ, Goundappa B, Flannery B, Lipsitch M, Cobey S. Evaluating reduced effectiveness after repeat influenza vaccination while accounting for confounding by recent infection and within-season waning. Medrxiv : the Preprint Server For Health Sciences. PMID 37016669 DOI: 10.1101/2023.03.12.23287173 |
0.408 |
|
| 2023 |
Hood N, Flannery B, Gaglani M, Beeram M, Wernli K, Jackson ML, Martin ET, Monto AS, Zimmerman R, Raviotta J, Belongia EA, McLean HQ, Kim S, Patel MM, Chung JR. Influenza Vaccine Effectiveness Among Children: 2011-2020. Pediatrics. PMID 36960655 DOI: 10.1542/peds.2022-059922 |
0.389 |
|
| 2023 |
Tartof SY, Xie F, Yadav R, Wernli KJ, Martin ET, Belongia EA, Gaglani M, Zimmerman RK, Talbot HK, Thornburg N, Flannery B, Chung JR. Prior SARS-CoV-2 Infection and COVID-19 Vaccine Effectiveness against Outpatient Illness during Widespread Circulation of SARS-CoV-2 Omicron Variant, US Flu VE Network. Medrxiv : the Preprint Server For Health Sciences. PMID 36711929 DOI: 10.1101/2023.01.10.23284397 |
0.629 |
|
| 2023 |
Tenforde MW, Weber ZA, DeSilva MB, Stenehjem E, Yang DH, Fireman B, Gaglani M, Kojima N, Irving SA, Rao S, Grannis SJ, Naleway AL, Kirshner L, Kharbanda AB, Dascomb K, ... ... Flannery B, et al. Vaccine effectiveness against influenza-associated urgent care, emergency department, and hospital encounters during the 2021-2022 season, VISION Network. The Journal of Infectious Diseases. PMID 36683410 DOI: 10.1093/infdis/jiad015 |
0.374 |
|
| 2023 |
Thomas CM, White EB, Kojima N, Fill MA, Hanna S, Jones TF, Newhouse CN, Orejuela K, Roth E, Winders S, Chandler DR, Grijalva CG, Schaffner W, Schmitz JE, DaSilva J, ... ... Flannery B, et al. Early and Increased Influenza Activity Among Children - Tennessee, 2022-23 Influenza Season. Mmwr. Morbidity and Mortality Weekly Report. 72: 49-54. PMID 36656786 DOI: 10.15585/mmwr.mm7203a1 |
0.382 |
|
| 2022 |
Kim SS, Chung JR, Talbot HK, Grijalva CG, Wernli KJ, Kiniry E, Martin ET, Monto AS, Belongia EA, McLean HQ, Gaglani M, Mamawala M, Nowalk MP, Moehling Geffel K, Tartof SY, ... ... Flannery B, et al. Effectiveness of two and three mRNA COVID-19 vaccine doses against Omicron- and Delta-Related outpatient illness among adults, October 2021-February 2022. Influenza and Other Respiratory Viruses. 16: 975-985. PMID 36825251 DOI: 10.1111/irv.13029 |
0.567 |
|
| 2022 |
Williams KV, Moehling Geffel K, Alcorn JF, Patricia Nowalk M, Levine MZ, Kim SS, Flannery B, Susick M, Zimmerman RK. Factors associated with humoral immune response in older adults who received egg-free influenza vaccine. Vaccine. PMID 36543682 DOI: 10.1016/j.vaccine.2022.12.041 |
0.347 |
|
| 2022 |
Price AM, Flannery B, Talbot HK, Grijalva CG, Wernli KJ, Phillips CH, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Mutnal M, Geffel KM, Nowalk MP, Tartof SY, et al. Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021-2022 Influenza Season. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 36504336 DOI: 10.1093/cid/ciac941 |
0.618 |
|
| 2022 |
Jackson ML, Phillips CH, Wellwood S, Kiniry E, Jackson LA, Martin ET, Monto AS, McLean HQ, Belongia EA, Gaglani M, Dunnigan K, Raiyani C, Murthy K, Flannery B, Chung JR. Burden of medically attended influenza infection and cases averted by vaccination - United States, 2016/17 through 2018/19 influenza seasons. Vaccine. PMID 36379754 DOI: 10.1016/j.vaccine.2022.11.011 |
0.412 |
|
| 2022 |
Gaglani M, Kim SS, Naleway AL, Levine MZ, Edwards L, Murthy K, Dunnigan K, Zunie T, Groom H, Ball S, Jeddy Z, Hunt D, Wesley MG, Sambhara S, Gangappa S, ... ... Flannery B, et al. Effect of Repeat Vaccination on Immunogenicity of Quadrivalent Cell-Culture and Recombinant Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized, Open-Label Trial. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 36031405 DOI: 10.1093/cid/ciac683 |
0.372 |
|
| 2022 |
Chung JR, Kim SS, Flannery B, Smith ME, Dunnigan K, Raiyani C, Murthy K, Gaglani M, Jackson ML, Jackson LA, Bear T, Moehling Geffel K, Nowalk MP, Zimmerman RK, Martin ET, et al. Vaccine-associated attenuation of subjective severity among outpatients with influenza. Vaccine. PMID 35710506 DOI: 10.1016/j.vaccine.2022.06.019 |
0.397 |
|
| 2022 |
Li ZN, Liu F, Jefferson S, Horner L, Carney P, Johnson MDL, King JP, Martin ET, Zimmerman RK, Wernli K, Gaglani M, Thompson M, Flannery B, Stevens J, Tumpey T, et al. Multiplex Detection of Antibody Landscapes to SARS-CoV-2/Influenza/Common Human Coronaviruses Following Vaccination or Infection with SARS-CoV-2 and Influenza. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 35684961 DOI: 10.1093/cid/ciac472 |
0.451 |
|
| 2022 |
Regan AK, Wesley MG, Gaglani M, Kim SS, Edwards LJ, Murthy K, Jeddy Z, Naleway AL, Flannery B, Dawood FS, Groom H. Consistency of self-reported and documented historical influenza vaccination status of US healthcare workers. Influenza and Other Respiratory Viruses. PMID 35415884 DOI: 10.1111/irv.12988 |
0.376 |
|
| 2022 |
Chung JR, Kim SS, Kondor RJ, Smith C, Budd AP, Tartof SY, Florea A, Talbot HK, Grijalva CG, Wernli KJ, Phillips CH, Monto AS, Martin ET, Belongia EA, McLean HQ, ... ... Flannery B, et al. Interim Estimates of 2021-22 Seasonal Influenza Vaccine Effectiveness - United States, February 2022. Mmwr. Morbidity and Mortality Weekly Report. 71: 365-370. PMID 35271561 DOI: 10.15585/mmwr.mm7110a1 |
0.629 |
|
| 2022 |
Williams KV, Zhai B, Alcorn JF, Patricia Nowalk M, Levine MZ, Kim SS, Flannery B, Moehling Geffel K, Jaber Merranko A, Nagg JP, Collins M, Susick M, Clarke KS, Zimmerman RK, Martin JM. A randomized controlled trial of antibody response to 2019-20 cell-based inactivated and egg-based live attenuated influenza vaccines in children and young adults. Vaccine. 40: 780-788. PMID 34952751 DOI: 10.1016/j.vaccine.2021.12.034 |
0.377 |
|
| 2021 |
Delahoy MJ, Mortenson L, Bauman L, Marquez J, Bagdasarian N, Coyle J, Sumner K, Lewis NM, Lauring AS, Flannery B, Patel MM, Martin ET. Influenza A(H3N2) Outbreak on a University Campus - Michigan, October-November 2021. Mmwr. Morbidity and Mortality Weekly Report. 70: 1712-1714. PMID 34882659 DOI: 10.15585/mmwr.mm7049e1 |
0.345 |
|
| 2021 |
Spencer S, Chung JR, Belongia EA, Sundaram M, Meece J, Coleman LA, Zimmerman RK, Nowalk MP, Moehling Geffel K, Ross T, Carter CE, Shay D, Levine M, Liepkalns J, Kim JH, ... ... Flannery B, et al. Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults. Influenza and Other Respiratory Viruses. PMID 34859584 DOI: 10.1111/irv.12933 |
0.368 |
|
| 2021 |
McLean HQ, Levine MZ, King JP, Flannery B, Belongia EA. Serologic response to sequential vaccination with enhanced influenza vaccines: Open label randomized trial among adults aged 65-74 years. Vaccine. PMID 34774360 DOI: 10.1016/j.vaccine.2021.10.072 |
0.356 |
|
| 2021 |
Kim SS, Chung JR, Belongia EA, McLean HQ, King JP, Nowalk MP, Zimmerman RK, Balasubramani GK, Martin ET, Monto AS, Lamerato LE, Gaglani M, Smith ME, Dunnigan KM, Jackson ML, ... ... Flannery B, et al. mRNA Vaccine Effectiveness against COVID-19 among Symptomatic Outpatients Aged ≥16 Years in the United States, February - May 2021. The Journal of Infectious Diseases. PMID 34498052 DOI: 10.1093/infdis/jiab451 |
0.37 |
|
| 2021 |
Griggs EP, Flannery B, Foppa IM, Gaglani M, Murthy K, Jackson ML, Jackson LA, Belongia EA, McLean HQ, Martin ET, Monto AS, Zimmerman RK, Balasubramani GK, Chung JR, Patel M, et al. Role of Age in Spread of Influenza, 2011-2019, U.S. Influenza Vaccine Effectiveness Network. American Journal of Epidemiology. PMID 34274963 DOI: 10.1093/aje/kwab205 |
0.367 |
|
| 2021 |
Dawood FS, Naleway AL, Flannery B, Levine MZ, Murthy K, Sambhara S, Gangappa S, Edwards L, Ball S, Beacham L, Belongia E, Bounds K, Cao W, Gross FL, Groom H, et al. Comparison of the Immunogenicity of Cell Culture-Based and Recombinant Quadrivalent Influenza Vaccines to Conventional Egg-Based Quadrivalent Influenza Vaccines among Healthcare Personnel Aged 18-64 Years: A Randomized Open-Label Trial. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 34245243 DOI: 10.1093/cid/ciab566 |
0.352 |
|
| 2021 |
Chung JR, Flannery B, Kim SS, Gaglani M, Raiyani C, Belongia EA, McLean HQ, Nowalk MP, Zimmerman RK, Jackson ML, Jackson LA, Martin ET, Monto AS, Patel M. Sample size considerations for mid-season estimates from a large influenza vaccine effectiveness network in the United States. Vaccine. PMID 33994240 DOI: 10.1016/j.vaccine.2021.05.004 |
0.374 |
|
| 2021 |
Jackson ML, Ferdinands J, Nowalk MP, Zimmerman RK, Kieke B, Gaglani M, Murthy K, Petrie JG, Martin ET, Chung JR, Flannery B, Jackson LA. Differences between Frequentist and Bayesian inference in routine surveillance for influenza vaccine effectiveness: a test-negative case-control study. Bmc Public Health. 21: 516. PMID 33726743 DOI: 10.1186/s12889-021-10543-z |
0.384 |
|
| 2021 |
Wu MJ, Chung JR, Kim SS, Jackson ML, Jackson LA, Belongia EA, McLean HQ, Gaglani M, Reis M, Beeram M, Martin ET, Monto AS, Nowalk MP, Zimmerman R, Santibanez TA, ... ... Flannery B, et al. Influenza vaccination coverage among persons seeking outpatient medical care for acute respiratory illness in five states in the United States, 2011-2012 through 2018-2019. Vaccine. PMID 33597114 DOI: 10.1016/j.vaccine.2021.01.065 |
0.402 |
|
| 2021 |
Chung JR, Kim SS, Jackson ML, Jackson LA, Belongia EA, King JP, Zimmerman RK, Nowalk MP, Martin ET, Monto AS, Gaglani M, Smith ME, Patel M, Flannery B. Clinical Symptoms Among Ambulatory Patients Tested for SARS-CoV-2. Open Forum Infectious Diseases. 8: ofaa576. PMID 33537361 DOI: 10.1093/ofid/ofaa576 |
0.33 |
|
| 2020 |
Tenforde MW, Kondor RJG, Chung JR, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Rao A, Kim SS, Stark TJ, ... ... Flannery B, et al. Effect of antigenic drift on influenza vaccine effectiveness in the United States - 2019-2020. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 33367650 DOI: 10.1093/cid/ciaa1884 |
0.399 |
|
| 2020 |
Hinojosa M, Shepard SS, Chung JR, King JP, McLean HQ, Flannery B, Belongia EA, Levine MZ. Impact of Immune Priming, Vaccination and Infection on Influenza A(H3N2) Antibody Landscapes in Children. The Journal of Infectious Diseases. PMID 33090202 DOI: 10.1093/infdis/jiaa665 |
0.435 |
|
| 2020 |
Balasubramani GK, Choi WS, Nowalk MP, Zimmerman RK, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Jackson ML, Jackson LA, Chung JR, Spencer S, Fry AM, ... ... Flannery B, et al. Relative effectiveness of high dose versus standard dose influenza vaccines in older adult outpatients over four seasons, 2015-16 to 2018-19. Vaccine. PMID 32800465 DOI: 10.1016/J.Vaccine.2020.08.011 |
0.38 |
|
| 2020 |
Flannery B, Meece JK, Williams JV, Martin ET, Gaglani M, Jackson ML, Talbot HK. Systematic testing for influenza and COVID-19 among patients with respiratory illness. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32687197 DOI: 10.1093/Cid/Ciaa1023 |
0.335 |
|
| 2020 |
Moehling KK, Zimmerman RK, Nowalk MP, Jeng Lin C, Martin JM, Alcorn JF, Susick M, Burroughs A, Holiday C, Flannery B, Levine MZ. A randomized controlled trial of antibody response to 2018-19 cell-based vs. egg-based quadrivalent inactivated influenza vaccine in children. Vaccine. PMID 32580919 DOI: 10.1016/j.vaccine.2020.06.023 |
0.352 |
|
| 2020 |
Kim SS, Flannery B, Foppa IM, Chung JR, Nowalk MP, Zimmerman RK, Gaglani M, Monto AS, Martin ET, Belongia EA, McLean HQ, Jackson ML, Jackson LA, Patel M. Effects of prior season vaccination on current season vaccine effectiveness in the US Flu VE Network, 2012-13 through 2017-18. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32505128 DOI: 10.1093/Cid/Ciaa706 |
0.328 |
|
| 2020 |
Chung JR, Flannery B, Gaglani M, Smith ME, Reis EC, Hickey RW, Jackson ML, Jackson LA, Belongia EA, McLean HQ, Martin ET, Segaloff HE, Kim SS, Patel MM. Patterns of Influenza Vaccination and Vaccine Effectiveness Among Young US Children Who Receive Outpatient Care for Acute Respiratory Tract Illness. Jama Pediatrics. PMID 32364599 DOI: 10.1001/jamapediatrics.2020.0372 |
0.398 |
|
| 2020 |
Patel M, Chen J, Kim S, Garg S, Flannery B, Haddadin Z, Rankin D, Halasa N, Talbot HK, Reed C. Analysis of MarketScan Data for Immunosuppressive Conditions and Hospitalizations for Acute Respiratory Illness, United States. Emerging Infectious Diseases. 26. PMID 32348234 DOI: 10.3201/eid2608.191493 |
0.339 |
|
| 2020 |
Smith ER, Fry AM, Hicks LA, Fleming-Dutra KE, Flannery B, Ferdinands J, Rolfes MA, Martin ET, Monto AS, Zimmerman RK, Nowalk MP, Jackson ML, McLean HQ, Olson SC, Gaglani M, et al. Reducing Antibiotic Use in Ambulatory Care through Influenza Vaccination. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32322875 DOI: 10.1093/Cid/Ciaa464 |
0.338 |
|
| 2020 |
Balasubramani GK, Nowalk MP, Sax TM, Suyama J, Bobyock E, Rinaldo CR, Martin ET, Monto AS, Jackson ML, Gaglani MJ, Flannery B, Chung JR, Zimmerman RK. Influenza vaccine effectiveness among outpatients in the US Influenza Vaccine Effectiveness Network by study site 2011-2016. Influenza and Other Respiratory Viruses. PMID 32298048 DOI: 10.1111/Irv.12741 |
0.392 |
|
| 2020 |
Tenforde MW, Chung J, Smith ER, Talbot HK, Trabue CH, Zimmerman RK, Silveira FP, Gaglani M, Murthy K, Monto AS, Martin ET, McLean HQ, Belongia EA, Jackson LA, Jackson ML, ... ... Flannery B, et al. Influenza vaccine effectiveness in inpatient and outpatient settings in the United States, 2015 - 2018. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32270198 DOI: 10.1093/Cid/Ciaa407 |
0.402 |
|
| 2020 |
Belongia EA, Levine MZ, Olaiya O, Gross FL, King JP, Flannery B, McLean HQ. Clinical trial to assess immunogenicity of high-dose, adjuvanted, and recombinant influenza vaccines against cell-grown A(H3N2) viruses in adults 65 to 74 years, 2017-2018. Vaccine. PMID 32145994 DOI: 10.1016/j.vaccine.2020.02.055 |
0.376 |
|
| 2020 |
Dawood FS, Chung JR, Kim SS, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Dunnigan K, Foust A, Sessions W, ... ... Flannery B, et al. Interim Estimates of 2019-20 Seasonal Influenza Vaccine Effectiveness - United States, February 2020. Mmwr. Morbidity and Mortality Weekly Report. 69: 177-182. PMID 32078591 DOI: 10.15585/Mmwr.Mm6907A1 |
0.429 |
|
| 2020 |
Doyle JD, Beacham L, Martin ET, Talbot HK, Monto A, Gaglani M, Middleton DB, Silveira FP, Zimmerman RK, Alyanak E, Smith ER, Flannery BL, Rolfes M, Ferdinands JM. Relative and absolute effectiveness of high-dose and standard-dose influenza vaccine against influenza-related hospitalization among older adults - United States, 2015-2017. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32067049 DOI: 10.1093/Cid/Ciaa160 |
0.38 |
|
| 2020 |
Gaglani M, Vasudevan A, Raiyani C, Murthy K, Chen W, Reis M, Belongia EA, McLean HQ, Jackson ML, Jackson LA, Zimmerman RK, Nowalk MP, Monto AS, Martin ET, Chung JR, ... ... Flannery B, et al. Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines against Influenza B in the United States, 2011-2012 to 2016-2017. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32006430 DOI: 10.1093/Cid/Ciaa102 |
0.371 |
|
| 2020 |
Chung JR, Rolfes MA, Flannery B, Prasad P, O'Halloran A, Garg S, Fry AM, Singleton JA, Patel M, Reed C. Effects of Influenza Vaccination in the United States during the 2018-2019 Influenza Season. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31905401 DOI: 10.1093/Cid/Ciz1244 |
0.404 |
|
| 2020 |
Flannery B, Fry AM. Comparing Influenza Vaccine Types: The Path Toward Improved Influenza Vaccine Strategies. The Journal of Infectious Diseases. 220: 1237-1239. PMID 30561690 DOI: 10.1093/infdis/jiy717 |
0.373 |
|
| 2019 |
Florek K, Mutschler J, McLean HQ, King JP, Flannery B, Belongia EA, Friedrich TC. Antibody-dependent cell-mediated cytotoxicity antibody responses to inactivated and live-attenuated influenza vaccination in children during 2014-15. Vaccine. PMID 31753674 DOI: 10.1016/j.vaccine.2019.10.060 |
0.398 |
|
| 2019 |
Flannery B, Kondor RJG, Chung JR, Gaglani M, Reis M, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Martin ET, Belongia EA, McLean HQ, Kim SS, Blanton L, et al. Spread of antigenically drifted influenza A(H3N2) viruses and vaccine effectiveness in the United States during the 2018-2019 season. The Journal of Infectious Diseases. PMID 31665373 DOI: 10.1093/Infdis/Jiz543 |
0.408 |
|
| 2019 |
Foppa IM, Ferdinands JM, Chung J, Flannery B, Fry AM. Vaccination history as a confounder of studies of influenza vaccine effectiveness. Vaccine: X. 1: 100008. PMID 31384730 DOI: 10.1016/j.jvacx.2019.100008 |
0.385 |
|
| 2019 |
Hughes MM, Reed C, Flannery B, Garg S, Singleton JA, Fry AM, Rolfes MA. Projected Population Benefit of Increased Effectiveness and Coverage of Influenza Vaccination on Influenza Burden - United States. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31344229 DOI: 10.1093/cid/ciz676 |
0.374 |
|
| 2019 |
Monto AS, Malosh RE, Evans R, Lauring AS, Gordon A, Thompson MG, Fry AM, Flannery B, Ohmit SE, Petrie JG, Martin ET. Data resource profile: Household Influenza Vaccine Evaluation (HIVE) Study. International Journal of Epidemiology. PMID 31038700 DOI: 10.1093/Ije/Dyz086 |
0.355 |
|
| 2019 |
Doyle JD, Chung JR, Kim SS, Gaglani M, Raiyani C, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Martin ET, Belongia EA, McLean HQ, Foust A, Sessions W, ... ... Flannery B, et al. Interim Estimates of 2018-19 Seasonal Influenza Vaccine Effectiveness - United States, February 2019. Mmwr. Morbidity and Mortality Weekly Report. 68: 135-139. PMID 30763298 DOI: 10.15585/Mmwr.Mm6806A2 |
0.439 |
|
| 2019 |
McLean HQ, King JP, Talley P, Flannery B, Spencer S, Levine MZ, Friedrich TC, Belongia EA. Effect of Previous-Season Influenza Vaccination on Serologic Response in Children During 3 Seasons, 2013-2014 Through 2015-2016. Journal of the Pediatric Infectious Diseases Society. PMID 30759228 DOI: 10.1093/jpids/piz001 |
0.377 |
|
| 2019 |
Rolfes MA, Flannery B, Chung J, O'Halloran A, Garg S, Belongia EA, Gaglani M, Zimmerman R, Jackson ML, Monto AS, Alden NB, Anderson E, Bennett NM, Billing L, Eckel S, et al. Effects of Influenza Vaccination in the United States during the 2017-2018 Influenza Season. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30715278 DOI: 10.1093/Cid/Ciz075 |
0.405 |
|
| 2019 |
Chung JR, Flannery B, Ambrose CS, Bégué RE, Caspard H, DeMarcus L, Fowlkes AL, Kersellius G, Steffens A, Fry AM. Live Attenuated and Inactivated Influenza Vaccine Effectiveness. Pediatrics. PMID 30617239 DOI: 10.1542/peds.2018-2094 |
0.355 |
|
| 2018 |
Shang M, Chung JR, Jackson ML, Jackson LA, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Fry AM, Flannery B. Influenza vaccine effectiveness among patients with high-risk medical conditions in the United States, 2012-2016. Vaccine. PMID 30420119 DOI: 10.1016/j.vaccine.2018.10.093 |
0.369 |
|
| 2018 |
Appiah GD, Chung JR, Flannery B, Havers F, Zimmerman RK, Nowalk MP, Monto AS, Martin ET, Gaglani M, Murthy K, Jackson LA, Jackson ML, McLean HQ, Belongia EA, Fry AM. Hospitalization following Outpatient Medical Care for Influenza: US Influenza Vaccine Effectiveness Network, 2011-12-2015-16. Influenza and Other Respiratory Viruses. PMID 30408341 DOI: 10.1111/Irv.12616 |
0.386 |
|
| 2018 |
Havers FP, Chung JR, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Petrie JG, Fry AM, Flannery B. Influenza Vaccine Effectiveness and Statin Use Among Adults in the United States, 2011-2017. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30371753 DOI: 10.1093/Cid/Ciy780 |
0.384 |
|
| 2018 |
Flannery B, Chung JR, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Rolfes MA, Spencer S, Fry AM, et al. Influenza Vaccine Effectiveness in the United States during the 2016-2017 Season. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30204854 DOI: 10.1093/Cid/Ciy775 |
0.398 |
|
| 2018 |
Flannery B, Chung JR, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Martin ET, Foust A, Sessions W, Berman L, et al. Interim Estimates of 2017-18 Seasonal Influenza Vaccine Effectiveness - United States, February 2018. Mmwr. Morbidity and Mortality Weekly Report. 67: 180-185. PMID 29447141 DOI: 10.1111/Ajt.14730 |
0.44 |
|
| 2018 |
Rolfes MA, Foppa IM, Garg S, Flannery B, Brammer L, Singleton JA, Burns E, Jernigan D, Olsen SJ, Bresee J, Reed C. Annual estimates of the burden of seasonal influenza in the United States: A tool for strengthening influenza surveillance and preparedness. Influenza and Other Respiratory Viruses. PMID 29446233 DOI: 10.1111/irv.12486 |
0.346 |
|
| 2018 |
King JP, McLean HQ, Meece JK, Levine MZ, Spencer SM, Flannery B, Belongia EA. Vaccine failure and serologic response to live attenuated and inactivated influenza vaccines in children during the 2013-2014 season. Vaccine. PMID 29395525 DOI: 10.1016/j.vaccine.2018.01.016 |
0.394 |
|
| 2018 |
Flannery B, Smith C, Garten RJ, Levine MZ, Chung JR, Jackson ML, Jackson LA, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman R, Nowalk MP, et al. Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States. The Journal of Infectious Diseases. PMID 29361005 DOI: 10.1093/Infdis/Jix634 |
0.379 |
|
| 2018 |
Rolfes MA, Gross FL, Flannery B, Meyers AFA, Luo M, Bastien N, Fowler RA, Katz JM, Levine MZ, Kumar A, Uyeki TM. Kinetics of serological responses in critically ill patients hospitalized with influenza A(H1N1)pdm09 virus infection in Canada, 2009-2011. The Journal of Infectious Diseases. PMID 29342251 DOI: 10.1093/Infdis/Jiy013 |
0.369 |
|
| 2017 |
Jackson ML, Phillips CH, Benoit J, Jackson LA, Gaglani M, Murthy K, McLean HQ, Belongia EA, Malosh R, Zimmerman R, Flannery B. Burden of medically attended influenza infection and cases averted by vaccination - United States, 2013/14 through 2015/16 influenza seasons. Vaccine. PMID 29249545 DOI: 10.1016/j.vaccine.2017.12.014 |
0.403 |
|
| 2017 |
Florek NW, Campos LM, Braun KM, McLean HQ, King JP, Flannery B, Belongia EA, Friedrich TC. An updated influenza A(H3N2) vaccine generates limited antibody responses to previously encountered antigens in children. Vaccine. PMID 29249543 DOI: 10.1016/j.vaccine.2017.12.024 |
0.371 |
|
| 2017 |
Dugan VG, Blanton L, Elal AIA, Alabi N, Barnes J, Brammer L, Burns E, Cummings CN, Davis T, Flannery B, Fry AM, Garg S, Garten R, Gubareva L, Jang Y, et al. Update: Influenza Activity - United States, October 1-November 25, 2017. Mmwr. Morbidity and Mortality Weekly Report. 66: 1318-1326. PMID 29216030 DOI: 10.15585/Mmwr.Mm6648A2 |
0.397 |
|
| 2017 |
Stewart RJ, Flannery B, Chung JR, Gaglani M, Reis M, Zimmerman RK, Nowalk MP, Jackson L, Jackson M, Monto AS, Martin ET, Belongia EA, McLean H, Fry AM, Havers F. Influenza Antiviral Prescribing for Outpatients with an Acute Respiratory Illness and at High Risk for Influenza-Associated Complications during Five Influenza Seasons-United States, 2011-2016. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 29069334 DOI: 10.1093/Cid/Cix922 |
0.308 |
|
| 2017 |
Jackson ML, Chung JR, Jackson LA, Phillips CH, Benoit J, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman R, Nowalk MP, Fry AM, Flannery B. Influenza Vaccine Effectiveness in the United States during the 2015-2016 Season. The New England Journal of Medicine. 377: 534-543. PMID 28792867 DOI: 10.1056/NEJMoa1700153 |
0.413 |
|
| 2017 |
Blanton L, Alabi N, Mustaquim D, Taylor C, Kniss K, Kramer N, Budd A, Garg S, Cummings CN, Chung J, Flannery B, Fry AM, Sessions W, Garten R, Xu X, et al. Update: Influenza Activity in the United States During the 2016-17 Season and Composition of the 2017-18 Influenza Vaccine. Mmwr. Morbidity and Mortality Weekly Report. 66: 668-676. PMID 28662019 DOI: 10.15585/Mmwr.Mm6625A3 |
0.327 |
|
| 2017 |
Chung JR, Flannery B, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Petrie JG, Martin ET, Monto AS, McLean HQ, Belongia EA, Gaglani M, Fry AM. Prior season vaccination and risk of influenza during the 2014-2015 season in the U.S. The Journal of Infectious Diseases. PMID 28633308 DOI: 10.1093/Infdis/Jix286 |
0.345 |
|
| 2017 |
Flannery B, Reynolds SB, Blanton L, Santibanez TA, O'Halloran A, Lu PJ, Chen J, Foppa IM, Gargiullo P, Bresee J, Singleton JA, Fry AM. Influenza Vaccine Effectiveness Against Pediatric Deaths: 2010-2014. Pediatrics. 139. PMID 28557757 DOI: 10.1542/peds.2016-4244 |
0.341 |
|
| 2017 |
Flannery B, Chung JR, Thaker SN, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Foust A, Sessions W, et al. Interim Estimates of 2016-17 Seasonal Influenza Vaccine Effectiveness - United States, February 2017. Mmwr. Morbidity and Mortality Weekly Report. 66: 167-171. PMID 28207689 DOI: 10.15585/Mmwr.Mm6606A3 |
0.44 |
|
| 2016 |
Ferdinands JM, Fry AM, Reynolds S, Petrie J, Flannery B, Jackson ML, Belongia EA. Intraseason waning of influenza vaccine protection: Evidence from the US Influenza Vaccine Effectiveness Network, 2011-12 through 2014-15. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 28039340 DOI: 10.1093/cid/ciw816 |
0.396 |
|
| 2016 |
Shang M, Blanton L, Kniss K, Mustaquim D, Alabi N, Barnes S, Budd A, Davlin SL, Kramer N, Garg S, Cummings CN, Flannery B, Fry AM, Grohskopf LA, Olsen SJ, et al. Update: Influenza Activity - United States, October 2-December 17, 2016. Mmwr. Morbidity and Mortality Weekly Report. 65: 1439-1444. PMID 28033315 DOI: 10.15585/Mmwr.Mm655051A5 |
0.366 |
|
| 2016 |
Zimmerman RK, Nowalk MP, Chung J, Jackson ML, Jackson LA, Petrie JG, Monto AS, McLean HQ, Belongia EA, Gaglani M, Murthy K, Fry AM, Flannery B. 2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 27702768 DOI: 10.1093/Cid/Ciw635 |
0.388 |
|
| 2016 |
Zimmerman RK, Balasubramani GK, Nowalk MP, Eng H, Urbanski L, Jackson ML, Jackson LA, McLean HQ, Belongia EA, Monto AS, Malosh RE, Gaglani M, Clipper L, Flannery B, Wisniewski SR. Classification and Regression Tree (CART) analysis to predict influenza in primary care patients. Bmc Infectious Diseases. 16: 503. PMID 27659721 DOI: 10.1186/S12879-016-1839-X |
0.314 |
|
| 2016 |
Budd A, Blanton L, Kniss K, Smith S, Mustaquim D, Davlin SL, Kramer N, Flannery B, Fry AM, Grohskopf LA, Olsen SJ, Bresee J, Sessions W, Garten R, Xu X, et al. Update: Influenza Activity - United States and Worldwide, May 22-September 10, 2016. Mmwr. Morbidity and Mortality Weekly Report. 65: 1008-1014. PMID 27657671 DOI: 10.15585/mmwr.mm6537a5 |
0.355 |
|
| 2016 |
Levine MZ, Martin JM, Gross FL, Jefferson S, Cole KS, Archibald C, Nowalk MP, Susick M, Moehling K, Spencer S, Chung JR, Flannery B, Zimmerman RK. Neutralizing Antibody Responses to Antigenically Drifted Influenza A(H3N2) viruses Among Children and Adolescents Following 2014-15 Inactivated and Live Attenuated Influenza Vaccination. Clinical and Vaccine Immunology : Cvi. PMID 27558294 DOI: 10.1128/CVI.00297-16 |
0.432 |
|
| 2016 |
Kim JH, Mishina M, Chung JR, Cole KS, Nowalk MP, Martin JM, Spencer S, Flannery B, Zimmerman RK, Sambhara S. Cell-mediated immunity against antigenically drifted influenza A(H3N2) viruses in children during a vaccine mismatch season. The Journal of Infectious Diseases. PMID 27534687 DOI: 10.1093/infdis/jiw311 |
0.375 |
|
| 2016 |
Petrie JG, Ohmit SE, Cheng CK, Martin ET, Malosh RE, Lauring AS, Lamerato LE, Reyes KC, Flannery B, Ferdinands JM, Monto AS. Influenza Vaccine Effectiveness against Antigenically Drifted Influenza Higher than Expected in Hospitalized Adults: 2014-2015. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 27369320 DOI: 10.1093/Cid/Ciw432 |
0.424 |
|
| 2016 |
Davlin SL, Blanton L, Kniss K, Mustaquim D, Smith S, Kramer N, Cohen J, Cummings CN, Garg S, Flannery B, Fry AM, Grohskopf LA, Bresee J, Wallis T, Sessions W, et al. Influenza Activity - United States, 2015-16 Season and Composition of the 2016-17 Influenza Vaccine. Mmwr. Morbidity and Mortality Weekly Report. 65: 567-575. PMID 27281364 DOI: 10.15585/Mmwr.Mm6522A3 |
0.375 |
|
| 2016 |
Flannery B, Zimmerman RK, Gubareva LV, Garten RJ, Chung JR, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Ohmit SE, Belongia EA, McLean HQ, Gaglani M, Piedra PA, Mishin VP, et al. Enhanced genetic characterization of influenza A(H3N2) viruses and vaccine effectiveness by genetic group, 2014-2015. The Journal of Infectious Diseases. PMID 27190176 DOI: 10.1093/Infdis/Jiw181 |
0.335 |
|
| 2016 |
Foppa IM, Ferdinands JM, Chaves SS, Haber MJ, Reynolds SB, Flannery B, Fry AM. The case test-negative design for studies of the effectiveness of influenza vaccine in inpatient settings. International Journal of Epidemiology. PMID 26979985 DOI: 10.1093/Ije/Dyw022 |
0.423 |
|
| 2016 |
Russell K, Blanton L, Kniss K, Mustaquim D, Smith S, Cohen J, Garg S, Flannery B, Fry AM, Grohskopf LA, Bresee J, Wallis T, Sessions W, Garten R, Xu X, et al. Update: Influenza Activity - United States, October 4, 2015-February 6, 2016. Mmwr. Morbidity and Mortality Weekly Report. 65: 146-53. PMID 26891596 DOI: 10.15585/mmwr.mm6506a3 |
0.357 |
|
| 2016 |
Fernandes EG, Leshem E, Patel M, Flannery B, Pellini AC, Veras MA, Sato HK. Hospital-based surveillance of intussusception among infants. Jornal De Pediatria. PMID 26804014 DOI: 10.1016/j.jped.2015.06.008 |
0.311 |
|
| 2016 |
Gaglani M, Pruszynski J, Murthy K, Clipper L, Robertson A, Reis M, Chung JR, Piedra PA, Avadhanula V, Nowalk MP, Zimmerman RK, Jackson ML, Jackson LA, Petrie JG, Ohmit SE, ... ... Flannery B, et al. Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States. The Journal of Infectious Diseases. PMID 26743842 DOI: 10.1093/Infdis/Jiv577 |
0.379 |
|
| 2016 |
Chung JR, Flannery B, Thompson MG, Gaglani M, Jackson ML, Monto AS, Nowalk MP, Talbot HK, Treanor JJ, Belongia EA, Murthy K, Jackson LA, Petrie JG, Zimmerman RK, Griffin MR, et al. Seasonal Effectiveness of Live Attenuated and Inactivated Influenza Vaccine. Pediatrics. PMID 26738884 DOI: 10.1542/Peds.2015-3279 |
0.407 |
|
| 2015 |
Thompson MG, Clippard J, Petrie JG, Jackson ML, McLean HQ, Gaglani M, Reis EC, Flannery B, Monto AS, Jackson L, Belongia EA, Murthy K, Zimmerman RK, Thaker S, Fry AM. Influenza Vaccine Effectiveness for Fully and Partially Vaccinated Children 6 months to 8 Years Old during 2011-2012 and 2012-2013: The Importance of Two Priming Doses. The Pediatric Infectious Disease Journal. PMID 26658375 DOI: 10.1097/Inf.0000000000001006 |
0.363 |
|
| 2015 |
Petrie JG, Cheng C, Malosh RE, VanWormer JJ, Flannery B, Zimmerman RK, Gaglani M, Jackson ML, King JP, Nowalk MP, Benoit J, Robertson A, Thaker SN, Monto AS, Ohmit SE. Illness Severity and Work Productivity Loss among Working Adults with Medically-Attended Acute Respiratory Illnesses: US Influenza Vaccine Effectiveness Network 2012-2013. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 26565004 DOI: 10.1093/Cid/Civ952 |
0.386 |
|
| 2015 |
Blanton L, Kniss K, Smith S, Mustaquim D, Steffens C, Flannery B, Fry AM, Bresee J, Wallis T, Garten R, Xu X, Elal AI, Gubareva L, Wentworth DE, Burns E, et al. Update: Influenza Activity - United States and Worldwide, May 24-September 5, 2015. Mmwr. Morbidity and Mortality Weekly Report. 64: 1011-6. PMID 26390411 DOI: 10.15585/mmwr.mm6436a4 |
0.357 |
|
| 2015 |
Jackson ML, Jackson LA, Kieke B, McClure D, Gaglani M, Murthy K, Malosh R, Monto A, Zimmerman RK, Foppa IM, Flannery B, Thompson MG. Incidence of medically attended influenza infection and cases averted by vaccination, 2011/2012 and 2012/2013 influenza seasons. Vaccine. 33: 5181-7. PMID 26271827 DOI: 10.1016/J.Vaccine.2015.07.098 |
0.411 |
|
| 2015 |
Suarez-Castaneda E, Burnett E, Elas M, Baltrons R, Pezzoli L, Flannery B, Kleinbaum D, Oliveira LH, Danovaro-Holliday MC. Catching-up with pentavalent vaccine: Exploring reasons behind lower rotavirus vaccine coverage in El Salvador. Vaccine. PMID 26263200 DOI: 10.1016/J.Vaccine.2015.07.092 |
0.332 |
|
| 2015 |
Cardoso CW, Ribeiro GS, Reis MG, Flannery B, Reis JN. Effectiveness of meningococcal C conjugate vaccine in salvador, Brazil: a case-control study. Plos One. 10: e0123734. PMID 25874777 DOI: 10.1371/journal.pone.0123734 |
0.318 |
|
| 2015 |
Havers F, Flannery B, Clippard JR, Gaglani M, Zimmerman RK, Jackson LA, Petrie JG, McLean HQ, Nowalk MP, Jackson ML, Monto AS, Belongia EA, Eng HF, Lamerato L, Campbell AP, et al. Use of influenza antiviral medications among outpatients at high risk for influenza-associated complications during the 2013-2014 influenza season. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 60: 1677-80. PMID 25722198 DOI: 10.1093/Cid/Civ146 |
0.342 |
|
| 2015 |
Flannery B, Clippard J, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Petrie JG, McLean HQ, Belongia EA, Gaglani M, Berman L, Foust A, Sessions W, Thaker SN, et al. Early estimates of seasonal influenza vaccine effectiveness - United States, January 2015. Mmwr. Morbidity and Mortality Weekly Report. 64: 10-5. PMID 25590680 |
0.438 |
|
| 2014 |
Reed C, Kim IK, Singleton JA, Chaves SS, Flannery B, Finelli L, Fry A, Burns E, Gargiullo P, Jernigan D, Cox N, Bresee J. Estimated influenza illnesses and hospitalizations averted by vaccination--United States, 2013-14 influenza season. Mmwr. Morbidity and Mortality Weekly Report. 63: 1151-4. PMID 25503917 |
0.422 |
|
| 2014 |
Domingues CM, de Fátima Pereira S, Cunha Marreiros AC, Menezes N, Flannery B. Introduction of sequential inactivated polio vaccine-oral polio vaccine schedule for routine infant immunization in Brazil's National Immunization Program. The Journal of Infectious Diseases. S143-51. PMID 25316829 DOI: 10.1093/infdis/jit588 |
0.316 |
|
| 2014 |
Havers F, Thaker S, Clippard JR, Jackson M, McLean HQ, Gaglani M, Monto AS, Zimmerman RK, Jackson L, Petrie JG, Nowalk MP, Moehling KK, Flannery B, Thompson MG, Fry AM. Use of influenza antiviral agents by ambulatory care clinicians during the 2012-2013 influenza season. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 59: 774-82. PMID 25034419 DOI: 10.1093/Cid/Ciu422 |
0.357 |
|
| 2014 |
Fernandes EG, Sato HK, Leshem E, Flannery B, Konstantyner TC, Veras MA, Patel MM. Impact of rotavirus vaccination on diarrhea-related hospitalizations in São Paulo State, Brazil. Vaccine. 32: 3402-8. PMID 24736002 DOI: 10.1016/j.vaccine.2014.04.015 |
0.306 |
|
| 2014 |
Flannery B, Thaker SN, Clippard J, Monto AS, Ohmit SE, Zimmerman RK, Nowalk MP, Gaglani M, Jackson ML, Jackson LA, Belongia EA, McLean HQ, Berman L, Foust A, Sessions W, et al. Interim estimates of 2013-14 seasonal influenza vaccine effectiveness - United States, February 2014. Mmwr. Morbidity and Mortality Weekly Report. 63: 137-42. PMID 24553196 |
0.447 |
|
| 2013 |
Pilishvili T, Chernyshova L, Bondarenko A, Lapiy F, Sychova I, Cohen A, Flannery B, Hajjeh R. Evaluation of the effectiveness of Haemophilus influenzae type b conjugate vaccine introduction against radiologically-confirmed hospitalized pneumonia in young children in Ukraine. The Journal of Pediatrics. 163: S12-8. PMID 23773588 DOI: 10.1016/j.jpeds.2013.03.025 |
0.363 |
|
| 2012 |
Cardoso CW, Pinto LL, Reis MG, Flannery B, Reis JN. Impact of vaccination during an epidemic of serogroup C meningococcal disease in Salvador, Brazil. Vaccine. 30: 5541-6. PMID 22749604 DOI: 10.1016/j.vaccine.2012.06.044 |
0.308 |
|
| 2012 |
Vieira JC, Carvalho MT, Checchia RL, Trombiere M, Flannery B. Survey of rubella knowledge and acceptability of rubella vaccination among Brazilian adults prior to mass vaccination. Revista Panamericana De Salud Publica = Pan American Journal of Public Health. 30: 335-41. PMID 22124692 |
0.301 |
|
| 2012 |
von Gottberg A, Cohen C, Whitelaw A, Chhagan M, Flannery B, Cohen AL, de Gouveia L, Plessis Md, Madhi SA, Klugman KP. Invasive disease due to Haemophilus influenzae serotype b ten years after routine vaccination, South Africa, 2003-2009. Vaccine. 30: 565-71. PMID 22119925 DOI: 10.1016/J.Vaccine.2011.11.066 |
0.309 |
|
| 2011 |
Segatto C, Samad S, Mengue SS, Rodrigues G, Flannery B, Toscano CM. Historical analysis of birth cohorts not vaccinated against rubella prior to national rubella vaccination campaign, Brazil. The Journal of Infectious Diseases. S608-15. PMID 21954255 DOI: 10.1093/infdis/jir357 |
0.318 |
|
| 2011 |
Zanella RC, Bokermann S, Andrade AL, Flannery B, Brandileone MC. Changes in serotype distribution of Haemophilus influenzae meningitis isolates identified through laboratory-based surveillance following routine childhood vaccination against H. influenzae type b in Brazil. Vaccine. 29: 8937-42. PMID 21945960 DOI: 10.1016/j.vaccine.2011.09.053 |
0.33 |
|
| 2011 |
Patel MM, López-Collada VR, Bulhões MM, De Oliveira LH, Bautista Márquez A, Flannery B, Esparza-Aguilar M, Montenegro Renoiner EI, Luna-Cruz ME, Sato HK, Hernández-Hernández Ldel C, Toledo-Cortina G, Cerón-RodrÃguez M, Osnaya-Romero N, MartÃnez-Alcazar M, et al. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. The New England Journal of Medicine. 364: 2283-92. PMID 21675888 DOI: 10.1056/NEJMoa1012952 |
0.313 |
|
| 2011 |
de Carvalho CX, Kipnis A, Thörn L, de Andrade JG, Pimenta F, Brandileone MC, Zanella RC, Flannery B, Sgambatti S, Andrade AL. Carriage of Haemophilus influenzae among Brazilian children attending day care centers in the era of widespread Hib vaccination. Vaccine. 29: 1438-42. PMID 21199703 DOI: 10.1016/j.vaccine.2010.12.045 |
0.342 |
|
| 2009 |
Lee EH, Corcino M, Moore A, Garib Z, Peña C, Sánchez J, Fernández J, Feris-Iglesias JM, Flannery B. Impact of Haemophilus influenzae type b conjugate vaccine on bacterial meningitis in the Dominican Republic. Revista Panamericana De Salud Publica = Pan American Journal of Public Health. 24: 161-8. PMID 19115543 DOI: 10.1590/s1020-49892008000900002 |
0.359 |
|
| 2008 |
Lee EH, Lewis RF, Makumbi I, Kekitiinwa A, Ediamu TD, Bazibu M, Braka F, Flannery B, Zuber PL, Feikin DR. Haemophilus influenzae type b conjugate vaccine is highly effective in the Ugandan routine immunization program: a case-control study. Tropical Medicine & International Health : Tm & Ih. 13: 495-502. PMID 18312475 DOI: 10.1111/j.1365-3156.2008.02027.x |
0.328 |
|
| 2007 |
Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W, Craig AS, Jackson D, Thomas A, Beall B, Lynfield R, Reingold A, Farley MM, Whitney CG. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. The Journal of Infectious Diseases. 196: 1346-54. PMID 17922399 DOI: 10.1086/521626 |
0.311 |
|
| 2002 |
Sarkar U, Nascimento SF, Barbosa R, Martins R, Nuevo H, Kalofonos I, Kalafanos I, Grunstein I, Flannery B, Dias J, Riley LW, Reis MG, Ko AI. Population-based case-control investigation of risk factors for leptospirosis during an urban epidemic. The American Journal of Tropical Medicine and Hygiene. 66: 605-10. PMID 12201599 DOI: 10.4269/Ajtmh.2002.66.605 |
0.452 |
|
| 2001 |
Flannery B, Pereira MM, De Freitas Velloso PL, De Castro Carvalho C, De Codes LG, De Saboia Orrico G, Ribeiro Dourado CM, Riley LW, Reis MG, Ko AI. Referral pattern of Leptospirosis cases during a large urban epidemic of dengue American Journal of Tropical Medicine and Hygiene. 65: 657-663. PMID 11716133 DOI: 10.4269/Ajtmh.2001.65.657 |
0.506 |
|
| 2001 |
Flannery B, Costa D, Carvalho FP, Guerreiro H, Matsunaga J, Da Silva ED, Ferreira AG, Riley LW, Reis MG, Haake DA, Ko AI. Evaluation of recombinant Leptospira antigen-based enzyme-linked immunosorbent assays for the serodiagnosis of leptospirosis. Journal of Clinical Microbiology. 39: 3303-10. PMID 11526167 DOI: 10.1128/Jcm.39.9.3303-3310.2001 |
0.512 |
|
| 2001 |
Guerreiro H, Croda J, Flannery B, Mazel M, Matsunaga J, Reis MG, Levett PN, Ko AI, Haake DA. Leptospiral Proteins Recognized during the Humoral Immune Response to Leptospirosis in Humans Infection and Immunity. 69: 4958-4968. PMID 11447174 DOI: 10.1128/Iai.69.8.4958-4968.2001 |
0.329 |
|
| Show low-probability matches. |
